Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 3:16:1598974.
doi: 10.3389/fneur.2025.1598974. eCollection 2025.

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson's disease

Yud Dan Liu  1 , Hui Fang Li  1 , Ya Xian Zhai  1 , Yun Xia Shen  2 , Jinmei Yang  2 , Li Mei He  2 , Ting Shen  2
Affiliations

Summary of the best evidence for non-pharmaceutical interventions for mild cognitive impairment in Parkinson's disease

Yud Dan Liu et al. Front Neurol. .

Abstract

Objective: This study aimed to synthesize and evaluate the best evidence for non-pharmacological interventions targeting mild cognitive impairment in Parkinson's disease (PD-MCI), thereby informing the development of cognitive management strategies for this population.

Methods: A systematic search was conducted across multiple databases (e.g., UpToDate, BMJ Best Practice, and Cochrane Library) up to November 2024. Two researchers independently screened literature, assessed quality using standardized tools (AGREE II, JBI criteria), and graded evidence.

Results: Thirteen studies were included (five guidelines, two clinical decisions, two systematic reviews, one meta-analysis, and three RCTs). Twenty evidence points were categorized into six themes: safety/efficacy, assessment, cognitive training, exercise, health education, and multi-strategy approaches.

Conclusion: This study consolidates evidence supporting non-pharmacological interventions for PD-MCI, offering actionable recommendations for clinical practice to delay progression to Parkinson's disease dementia (PDD).

Keywords: Parkinson’s disease; best evidence; evidence summary; mild cognitive impairment; non-pharmacological interventions.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart of literature screening.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Jellinger KA. Pathobiology of cognitive impairment in Parkinson disease: challenges and outlooks. Int J Mol Sci. (2023) 25:498. doi: 10.3390/ijms25010498, PMID: - DOI - PMC - PubMed
    1. GBD 2019 Dementia Collaborators . The burden of dementia due to down syndrome, Parkinson's disease, stroke, and traumatic brain injury: a systematic analysis for the global burden of disease study 2019. Neuroepidemiology. (2021) 55:286–96. doi: 10.1159/000515393, PMID: - DOI - PMC - PubMed
    1. Kalbe E, Folkerts AK, Witt K, Buhmann C, Liepelt-Scarfone I, German Parkinson’s Guidelines Group . German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson's disease: new spotlights on diagnostic procedures and non-pharmacological interventions. J Neurol. (2024) 271:7330–57. doi: 10.1007/s00415-024-12503-0, PMID: - DOI - PMC - PubMed
    1. Zhu Z, Hu Y, Xing W. Components of evidence-based questions. J Nurse Train. (2017) 32:1991–4. doi: 10.16821/j.cnki.hsjx.2017.21.025 - DOI
    1. Alper BS, Haynes RB. EBHC pyramid 5.0 for accessing preappraised evidence and guidance. Evid Based Med. (2016) 21:123–5. doi: 10.1136/ebmed-2016-110447, PMID: - DOI - PubMed

Publication types

LinkOut - more resources